zhangjie
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pyrotinib Combined With Trastuzumab for Maintenance Therapy After First-line TH (P) Therapy for HER2+ABC (NCT06754059) | zhangjie | 2021-06-01 |
Track zhangjie automatically
Every clearance here is in the API, with alerts when new ones post.